Research project 27 November 2008 MEDICINE NOW Wellcome Collection Medicine Now is a permanent collection on display at the Wellcome Exhibition Centre. Embodying Henry Wellcome’s vision to educate and inform‚ curators‚ Steve Cross and Ken Arnold have combined current medical issues with artistic response. Elements of the Wunderkammer approach are used by designer Gitta Gschwendtner. This encourages visitors to open cabinet drawers‚ thereby engaging them more fully. The 350m2 open plan space
Premium 2008
“Measuring the effectiveness of display of LG product in dealer’s outlet “ A report submitted in the partial fulfillment of the requirements of MBA Program of M.P.Birla Institute of Management Under the guidance of Faculty guide Prof. Sumitra sreenath By Ashish Singh 06XQCM6013 M.P.B.I.M‚ Bangalore Acknowledgements At the onset I would like to express my sincere gratitude to the management and staff of LG Electronics India Pvt. Ltd. for their immense cooperation‚ which made this
Premium Brand Brand management
AZT Pricing Decision In 1986‚ Burroughs-Wellcome Company introduced the first major breakthrough against acquired immune deficiency syndrome (AIDS). It was the life-prolonging drug AZT. The product has turned out to be very successful for the company and‚ largely because of AZT’s success‚ Burroughs-Wellcome’s profits have doubled in the three years ending in 1988. The Food and Drug Administration (FDA) plans to expand the authorization for the drug’s usage to those who are
Premium Pharmacology Pharmaceutical drug Medicine
Pharmaceutical Mergers: What’s the Rush? Drivers of Recent and Future M&A Activity TABLE OF CONTENTS i) Executive Summary ii) Introduction iii) Industry Structure iv) Reasons for Recent M&A Activity v) Analysis of Two Recent Mega-Mergers – Glaxo Wellcome / SmithKline Beecham – Pfizer
Premium Pharmaceutical industry Pharmacology Drug discovery
Burroughs Wellcome Company‚ Case 6 In 1982‚ the Center for Disease Control and Prevention (CDCP) labeled the acquired immune deficiency syndrome (AIDS) and began to warn the public of the disease. In 1983 and 1984‚ the virus that causes AIDS was isolated and in 1988 it was named the human immunodeficiency virus (HIV). Burroughs Wellcome Company is a subsidiary of Wellcome PLC. Wellcome PLC is a pharmaceutical firm that employs 20‚000 people in 18 countries. Wellcome PLC produces both ethical
Premium HIV AIDS Drug discovery
PROJECT REPORT ON A Successful International Merger in India: GlaxoSmithKline pharmaceutical industry Table of Contents: Declaration Abstract Part I –Introduction Research Objective and justifications Report Outline Part-II Industry Description
Premium Mergers and acquisitions Pharmaceutical industry
Glaxo Italia S.p.A. is introducing the new drug‚ Zinnat‚ into the market. Glaxo has the option to directly sell or co-market the pharmaceutical. If the company were to sell the product directly‚ Glaxo’s sales force would be the sole distributors of the drug. Using co-marketing‚ Glaxo would allow another company to sell the same product under a different brand name for a fee. We have compared the two options to determine which marketing strategy would be in the best interest of Glaxo Italia in terms
Premium Net present value Time value of money Marketing
What is Merger and Acquisition (M&A)? Acquisitions and mergers mostly happen when a company wants to expand in a new territory‚ but does not have enough expertise to do business over there‚ or when a company wants to expand into a new business and does not have technologies to produce that new kind of product or service. Merger and acquisition doesn’t require any sort of subsidiary or joint venture. It is a decision taken by the top management of the company meaning it is a corporate level strategy
Premium Mergers and acquisitions Stock market
Clarissa Kowalczyk April 3 2012 MAR 499 Case Analysis Burroughs Wellcome Company: Retrovir Summary and Recommendation: As I have read the case it was presented that in January of 1990‚ Burroughs Wellcome executives were under continued pressure to reduce the price of Retrovir‚ a drug which had been found to be effective in the treatment of acquired immune deficiency syndrom (AIDS) and human immunodeficiency virus (HIV). After careful review of the data and the case I have come up with the
Premium AIDS Immune system Antiretroviral drug
Core issue: The case describes the events which lead to the merger of two large pharmaceutical giant Glaxo welcome and SmithKline beecham which lead to the formation of the entity GlaxoSmithKline. The core concern of the case is that although the newly merged company has invested heavily in R&D there is little evidence of success. Identification of supporting issues: These are some of the other issues that came up in the case which lead to the overall lack of success: * Significant
Premium